Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SHINECO (SISI : NSDQ)

• Company Description    Shineco, Inc. is principally engaged in the production and distribution of herbal medicines, organic agricultural produce, specialized textiles and other health and well-being focused plant-based products primarily in China. Shineco, Inc. is headquartered in Beijing, China. Number of Employees: 119

• Price / Volume Information    Yesterday's Closing Price: $0.18 Daily Weekly Monthly 20 Day Moving Average: 3,098,875 shares Shares Outstanding: 20.75 (millions) Market Capitalization: $3.82 (millions) Beta: -0.91 52 Week High: $28.32 52 Week Low: $0.15 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -42.12% -44.28% 12 Week -68.02% -73.10% Year To Date -95.94% -96.20%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Room 1707 Block D Modern City SOHO No. 88 Jianguo Road Chaoyang District - Beijing,F4 100022 CHN ph: 86-10-8722-7366 fax: - david.rudnick@preceptir.com http://www.biosisi.com

• General Corporate Information    Officers Jennifer Zhan - Chief Executive Officer and Director Mike Zhao - Chair of the Board Xiqiao Liu - Chief Operating Officer and Director Sai (Sam) Wang - Chief Financial Officer and Director Jin Liu - Director Peer Information SHINECO (GSAC) SHINECO (CASI) SHINECO (ALCD.) SHINECO (OMNN) SHINECO (CGPI.) SHINECO (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 824567507 SIC: 100 Fiscal Year Fiscal Year End: June Last Reported Quarter: 03/01/25 Next Expected EPS Date: 09/29/25 Share - Related Items Shares Outstanding: 20.75 Most Recent Split Date: 11.00 (0.04:1) Beta: -0.91 Market Capitalization: $3.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/29/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.12 Price/Cash Flow: - Price / Sales: 0.34 EPS Growth vs. Year Ago Period: 93.26% vs. Previous Quarter: 6.67% Sales Growth vs. Year Ago Period: -80.83% vs. Previous Quarter: -91.51% ROE 06/30/25 - - 03/31/25 - -79.89 12/31/24 - -71.22 ROA 06/30/25 - - 03/31/25 - -33.01 12/31/24 - -32.08 Current Ratio 06/30/25 - - 03/31/25 - 0.72 12/31/24 - 0.86 Quick Ratio 06/30/25 - - 03/31/25 - 0.71 12/31/24 - 0.82 Operating Margin 06/30/25 - - 03/31/25 - -265.19 12/31/24 - -245.33 Net Margin 06/30/25 - - 03/31/25 - -380.55 12/31/24 - -221.08 Pre-Tax Margin 06/30/25 - - 03/31/25 - -289.68 12/31/24 - -242.98 Book Value 06/30/25 - - 03/31/25 - 1.50 12/31/24 - 24.50 Inventory Turnover 06/30/25 - - 03/31/25 - 6.87 12/31/24 - 5.69 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.04 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 3.80

Powered by Zacks Investment Research ©